FDA Inspection 1095950 — Curium US LLC
The FDA completed an inspection of Curium US LLC on June 14, 2019 in Noblesville, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Noblesville, IN (United States)